Journal Report

Translational and Clinical Pharmacology

Download PDF
Journal Information
Journal Title
Translational and Clinical Pharmacology
Publisher
Korean Society Clinical Pharmacology and Therapeutics
ISSN
2289-0882
E-ISSN
2383-5427
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
The evolving landscape of inflammation-related clinical trials: a 25-year registry-based network analysis from a clinical pharmacology perspective
Sooyoun Lee, Kyung-Sang Yu, Ki Young Huh
2026 Vol. 34 Issue 3 Pages 154
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)
Kyungrin Chang, Heejae Won, Taewon Lee et al.
2026 Vol. 34 Issue 1 Pages 45
Implementation of decentralized clinical trials in Korea from a resource-based perspective
Ki Young Huh, Gaeun Kang, Kye Hun Kim
2026 Vol. 34 Issue 2 Pages 100
Development and evaluation of automated screening algorithms for pre-analytical errors in pharmacokinetic data: a simulation-based study
Minsub Shim, Jaegu Kang, Kyung-Sang Yu et al.
2026 Vol. 34 Issue 2 Pages 71
Development of a predictive platform for target concentration intervention of aminoglycosides
Kyung Ran Mun, Shi Hyang Lee, Hyeong-Seok Lim
2026 Vol. 34 Issue 3 Pages 139
The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens
Simona Stankeviciute, Ariel Tsai, Noha Rayad et al.
2026 Vol. 34 Issue 1 Pages 1
Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016–2024)
So Jin Lee, Soo Hyeon Bae, Jinha Park et al.
2026 Vol. 34 Issue 1 Pages 15
Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants
Jun Ki Hong, Hyun Chul Kim, In-Jin Jang et al.
2026 Vol. 34 Issue 2 Pages 88
Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records
Seunghwan Baek, JungJin Oh, SiYeon Yoon et al.
2026 Vol. 34 Issue 1 Pages 35
Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants
Hyungji Jang, Juyoung Khwarg, Ki Young Huh et al.
2026 Vol. 34 Issue 2 Pages 116
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 03:16